Search
Showing 1 - 15 of 15 results
News
UCSF Research Vital to First Drug for Deadly Bone Disease
The U.S. Food and Drug Administration (FDA) recently approved palovarotene (Sohonos) as the first treatment for fibrodysplasia ossifcans progressiva (FOP), a severely disabling condition that causes abnormal bone formation in place of soft and connective tissues.
News
Researchers Identify New Glucose Control Target That Could Lead to Novel Therapeutic Approaches
A 2017 study co-led by UCSF researchers found that a high-fat diet (HFD) is associated with the accumulation of inflammatory cells called microglia in the hypothalamus, which in turn increases the susceptibility of mice to overeat and gain excess weight.
News
Can What Works to Treat Cancer Work for Diabetes?
To live with type 1 diabetes is to be ruled by relentless routine. Food must be carefully monitored, and the only treatment, subcutaneous insulin, is burdensome...
News
New Hypoparathyroidism Guidelines and Emerging PTH Replacement Therapies for Improved Patient Outcomes
New guidelines from the Second International Workshop on the Evaluation and Management of Hypoparathyroidism provide clinicians with the latest evidence-based recommendations for the prevention, diagnosis and management of this rare disease.
News
Low-Risk Differentiated Thyroid Cancer Case Studies: Patient-Centered Approaches to Treatment
A 2022 UCSF study found that, since publication of the 2015 American Thyroid Association (ATA) guidelines, surgeons nationwide are performing more thyroid lobectomies for low-risk differentiated thyroid cancer (DTC) proportional to other thyroid surgeries for the condition.
News
UCSF Internal Medicine Specialist Celebrated for Diabetes Epidemiology Research
Alka M. Kanaya, MD, UC San Francisco primary care physician and researcher, has been honored with the 2023 Kelly West Award for Outstanding Achievement in Epidemiology from the American Diabetes Association (ADA).
News
UCSF Research Instrumental in Approval of Breakthrough Diabetes Therapy
The US Food and Drug Administration (FDA) recently approved the use of a new drug Teplizumab, an immunotherapy drug which has been shown to significantly delay the onset of type 1 diabetes.
News
Autoantibody for Acquired Lipodystrophy Identified, Bringing Hope for Therapeutics
UCSF investigators have found an autoantibody biomarker for acquired lipodystrophy, paving the way for novel treatment options for this complex condition, which causes adipose tissue loss and metabolic complications.
News
New Research Linking Type 1 Diabetes to Genetic Mutations May Lead to Precision Medicine
UCSF researchers have discovered specific genetic mutations that can cause type 1 diabetes. This groundbreaking work could result in effective precision treatments for patients.
News
UCSF Case Study: Same-Day Discharge After Pheochromocytoma Removal
San Francisco endocrine surgeon Sanziana Roman, MD, performed a posterior retroperitoneoscopic adrenalectomy (PRA) to remove a pheochromocytoma. This approach enabled the patient to be discharged home within hours of surgery and avoid prolonged hospitalization, thereby minimizing COVID-19 risk.
News
Activating Immune Surveillance Mechanisms Shows Promise for Treating Diabetes and Pulmonary Fibrosis
Researchers at UC San Francisco recently found that activating invariant natural killer T (iNKT) cells eliminated inflammatory senescent cells associated with chronic diseases in vivo. In the study, obese mice showed improved glucose control and mice with pulmonary fibrosis had decreased lung fibrosis and increased survival.
News
Virtual Inpatient Diabetes Management Tools Minimize COVID-19 Risk for Staff and Improve Patient Outcomes
Automated virtual tools for inpatient diabetes management in use at UC San Francisco have helped the medical staff deliver safe and effective patient care while reducing their exposure to SARS-CoV-2.
News
UCSF’s Julie Ann Sosa, MD, Named President-Elect of the American Thyroid Association
Julie Ann Sosa, MD, MA, FACS, endocrine surgeon and chair of the Department of Surgery at UC San Francisco, has been named president-elect of the American Thyroid Association (ATA). She was previously the ATA’s treasurer.
Document
UCSF MD Link: Web-Based Communication Portal for Physicians
Our web portal allows referring physicians to securely access their patients’ entire electronic health record, make online referral requests and communicate with our physicians directly and securely.
Document
Now Scheduling Referrals Within 24 Hours
Quan-Yang Duh, MD, Chief, Section of Endocrine Surgery, UCSF, and Sanziana Roman, MD, Medical Director, Endocrine Neoplasia Clinic, UCSF, provide an update on safe endocrine surgical patient care at UCSF.
